Sandoz will maintain stable pricing for coronavirus-related essential medicines that it markets, CEO Richard Saynor has pledged, amid ongoing concerns over the potential short-term and longer-term impacts of the outbreak on the supply chain.
As “the number one provider of off-patent antibiotic medicines worldwide,” Sandoz said it was “making a public commitment to ensure...



